BofA/Merrill Lynch analyst Ying Huang reiterated a Buy rating and $136 price target on Celgene (NASDAQ: CELG) after the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE